Daniel C. Chung DO, MA

Daniel Chung graduated from Eastern Nazarene College and pursued his medical training at the New York College of Osteopathic Medicine. He carried out additional laboratory training as an ocular gene therapy fellow at NEI/NIH and clinical training at the Cleveland Clinic Foundation ant the University of Pennsylvania. Dr Chung was the recipient of a mentored clinical scientist development award from the NEI/NIH and used this training to become an expert in ocular gene therapy. Dr Chung has trained colleagues in subretinal injections in small mammals at numerous institutions around the world. His interests are in viral and non-viral gene transfer for retinal degeneration and also ciliary disease involving other organ systems.

Dr Chung has participated in all phases of The Children’s Hospital of Philadelphia gene therapy clinical trials for Leber’s congenital amaurosis due to RPE65 mutations, including the current Phase 3 study. Among his contributions to those studies are the development and implementation of outcome measures and the assembly of natural history data of the disease. Dr Chung moved from UPenn to Spark Therapeutics in December 2014. In his free time, he is an aspiring nature photographer, enjoys activities with his wife and three children, is committed to his faith and church and to his diverse endeavours including fishing, hiking, camping, gardening, and cooking. Dan Chung left for Spark Therapeutics in December 2014.